SAN DIEGO and VANCOUVER, BC, Feb. 9, 2022 /PRNewswire/ - Phoenix Molecular Designs (PhoenixMD), a clinical stage biopharmaceutical company dedicated to developing precise cancer therapeutics, today ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback